To further investigate this possibility in cells with a naturally-occurring pathogenic BRCA1 mutation, we generated two independent SHLD2 knockout clones (G1 and D1) from BRCA1 mutant MDA-MB-436 breast cancer cells (Supplementary Fig. 3c, d). This evidence concerns the gene SHLD2 and breast cancer.